Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Mick00333on Feb 25, 2021 12:47pm

147 Views

Post# 32658959

Buy or not**

I'm just saying that we dont give a fuk of who said what and who didnt said it also we dont give a fuk about if u gonna get out Just do it and thats it u dont need to do 50 post to say samething again and again.. The keeper will stay here and talk and give advice or anything like we supose to and the leaver just leave without saying sh*t about KLY thanks you.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?